Duchesnay acquires Osphena U.S. rights from Shionogi
BLAINVILLE, Quebec, and OSAKA, Japan — Specialty pharmaceutical company Duchesnay has acquired exclusive U.S. and Canadian rights to market and distribute Osphena (ospemifene), a treatment for painful intercourse, from Shionogi Inc. The companies said the transaction gives Duchesnay the rights to develop, manufacture and commercialize ospemifene-based products in the United States and Canada. Duchesnay said
